Michelle L. Hill

Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

A broadly neutralizing antibody recognizes a unique epitope with a signature motif common across coronaviruses.

A broadly neutralizing antibody recognizes a unique epitope with a signature motif common across coronaviruses.

Journal: Nature communications

Published: January 30, 2025

Assessment of repurposed compounds against coronaviruses highlights the antiviral broad-spectrum activity of host-targeting iminosugars and confirms the activity of potent directly acting antivirals.

Assessment of repurposed compounds against coronaviruses highlights the antiviral broad-spectrum activity of host-targeting iminosugars and confirms the activity of potent directly acting antivirals.

Journal: Antiviral research

Published: October 22, 2024

Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.

Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: September 19, 2024

Determination of resilience of a panel of broadly neutralizing mAbs to emerging variants of SARS-CoV-2 generated using reverse genetics.

Determination of resilience of a panel of broadly neutralizing mAbs to emerging variants of SARS-CoV-2 generated using reverse genetics.

Journal: iScience

Published: August 30, 2024

Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2.

Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2.

Journal: Open biology

Published: June 05, 2024

An Update on SARS-CoV-2 Clinical Trial Results-What We Can Learn for the Next Pandemic.

An Update on SARS-CoV-2 Clinical Trial Results-What We Can Learn for the Next Pandemic.

Journal: International journal of molecular sciences

Published: November 28, 2023

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.

Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.

Journal: Science (New York, N.Y.)

Published: November 09, 2023

Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses.

Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses.

Journal: Nature nanotechnology

Published: March 20, 2023

Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology.

Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology.

Journal: bioRxiv : the preprint server for biology

Published: March 03, 2023

Exploring the Potential of Iminosugars as Antivirals for Crimean-Congo Haemorrhagic Fever Virus, Using the Surrogate Hazara Virus: Liquid-Chromatography-Based Mapping of Viral N-Glycosylation and In Vitro Antiviral Assays.

Exploring the Potential of Iminosugars as Antivirals for Crimean-Congo Haemorrhagic Fever Virus, Using the Surrogate Hazara Virus: Liquid-Chromatography-Based Mapping of Viral N-Glycosylation and In Vitro Antiviral Assays.

Journal: Pathogens (Basel, Switzerland)

Published: December 29, 2022

N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.

N-Substituted Valiolamine Derivatives as Potent Inhibitors of Endoplasmic Reticulum α-Glucosidases I and II with Antiviral Activity.

Journal: Journal of medicinal chemistry

Published: December 06, 2021

Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.

Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.

Journal: mSphere

Published: August 11, 2021

Showing 1-12 of 23

Last Updated: 09/26/2026